The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Fullerene-based antioxidants and neurodegenerative disorders.
Abstract
Water-soluble derivatives of buckminsterfullerene (C(60)) derivatives are a unique class of compounds with potent antioxidant properties. Studies on one class of these compounds, the malonic acid C(60) derivatives (carboxyfullerenes), indicated that they are capable of eliminating both superoxide anion and H(2)O(2), and were effective inhibitors of lipid peroxidation, as well. Carboxyfullerenes demonstrated robust neuroprotection against excitotoxic, apoptotic and metabolic insults in cortical cell cultures. They were also capable of rescuing mesencephalic dopaminergic neurons from both MPP(+) and 6-hydroxydopamine-induced degeneration. Although there is limited in vivo data on these compounds to date, we have previously reported that systemic administration of the C(3) carboxyfullerene isomer delayed motor deterioration and death in a mouse model of familial amyotrophic lateral sclerosis (FALS). Ongoing studies in other animal models of CNS disease states suggest that these novel antioxidants are potential neuroprotective agents for other neurodegenerative disorders, including Parkinson's disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Neuroprotective compounds based on carbon-60 fullerene – the molecules having a 3-D pattern of evenly spaced carbon atoms, have been fabricated by the application of nanotechnological approach (Dugan et al., 2001).”
From Nanotechnology: A Promising Approach for Delivery of Neuroprotective Drugs (2020) · cites this paper as Dugan et al., 2001
In the citing paper
“Free radicals, such as superoxide, hydroxyl, peroxynitrite, and peroxide, cause deleterious alterations in cells including DNA fragmentation, peroxidation of cell membrane lipids, mitochondrial energy disturbances and alteration in functionality of transporter proteins”
From Nanotechnology: A Promising Approach for Delivery of Neuroprotective Drugs (2020) · cites this paper as Dugan et al., 2001
In the citing paper
“they are considered as the main culprit having the key role in pathology of neurodegenerative, ischemic, and traumatic CNS disorders (Mahadik and Mukherjee, 1996; Dugan et al., 2001).”
From Nanotechnology: A Promising Approach for Delivery of Neuroprotective Drugs (2020) · cites this paper as Dugan et al., 2001
Citations
Cites
Carboxyfullerenes as neuroprotective agents
Dugan, L. L., Turetsky, D. M., Du, C., Lobner, D., Wheeler, M. E., Almli, C. R., Shen, C. K.-F., Luh, T., Choi, D. W., & Lin, T. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.17.9434 · Cited by 747
Self-citationDistinct mechanisms underlie neurotoxin-mediated cell death in cultured dopaminergic neurons
Lotharius, J., Dugan, L. L., & O’Malley, K. L. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-04-01284.1999 · Cited by 403
Self-citationDugan, L. L., Gabrielsen, J. K., Yu, S. P., Lin, T., & Choi, D. W. (1996) · Neurobiology of Disease · doi:10.1006/nbdi.1996.0013 · Cited by 384
Self-citationCarboxyfullerene Prevents Iron‐Induced Oxidative Stress in Rat Brain
Lin, A. M.-Y., Chyi, B. Y., Wang, S. D., Yu, H., Kanakamma, P. P., Luh, T., Chou, C., & Ho, L. T. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.721634.x · Cited by 136
C 3 ‐Fullero‐ tris ‐Methanodicarboxylic Acid Protects Cerebellar Granule Cells from Apoptosis
Bisaglia, M., Natalini, B., Pellicciari, R., Straface, E., Malorni, W., Monti, D., Franceschi, D., & Schettini, G. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.741197.x · Cited by 94
Rapid microplate assay for superoxide scavenging efficiency
Quick, K. L., Hardt, J. I., & Dugan, L. L. (2000) · Journal of Neuroscience Methods · doi:10.1016/s0165-0270(00)00179-5 · Cited by 90
Self-citationHuang, Y., Shen, C. K.-F., Luh, T., Yang, H. C., Hwang, K. C., & Chou, C. (1998) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1998.2540038.x · Cited by 86
Inhibition of Nitric Oxide Synthase Isoforms by Tris-Malonyl-C60-Fullerene Adducts
Wolff, D. J., Papoiu, A. D. P., Mialkowski, K., Richardson, C. F., Schuster, D. I., & Wilson, S. R. (2000) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2000.1843 · Cited by 59
Straface, E., Natalini, B., Monti, D., Franceschi, C., Schettini, G., Bisaglia, M., Fumelli, C., Pincelli, C., Pellicciari, R., & Malorni, W. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00812-1 · Cited by 52
Cited by
Sorted by citations
Items 101–200 of 337
Takada, H., Kokubo, K., Matsubayashi, K., & Oshima, T. (2006) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.60491 · Cited by 61
Nanobiomaterials’ applications in neurodegenerative diseases
Silva‐Adaya, D., Aguirre‐Cruz, L., Guevara, J., & Ortiz-Islas, E. (2016) · Journal of Biomaterials Applications · doi:10.1177/0885328216659032 · Cited by 62
On the Mechanism of Action of Fullerene Derivatives in Superoxide Dismutation
Osuna, S., Swart, M., & Solà, M. (2010) · Chemistry - A European Journal · doi:10.1002/chem.200902728 · Cited by 61
Chaturvedi, R. K., Shukla, S., Seth, K., & Agrawal, A. K. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2005.12.042 · Cited by 60
Theranostic implications of nanotechnology in multiple sclerosis: a future perspective.
Singh, A. V., Khare, M., Gade, W. N., & Zamboni, P. (2012) · Autoimmune Diseases · doi:10.1155/2012/160830 · Cited by 58
Rasool, M. A., Sattar, R., Anum, A., Al‐Hussain, S. A., Ahmad, S., Irfan, A., & Zaki, M. E. A. (2022) · Catalysts · doi:10.3390/catal13010066 · Cited by 59
Nanocarriers of nanotechnology in retinal diseases
Al-Halafi, A. M. (2014) · Saudi Journal of Ophthalmology · doi:10.1016/j.sjopt.2014.02.009 · Cited by 57
High Catalytic Activity of Dendritic C60 Monoadducts in Metal‐Free Superoxide Dismutation
Liu, G., Filipović, M. R., Ivanović‐Burmazović, I., Beuerle, F., Witte, P., & Hirsch, A. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200800008 · Cited by 57
Insights into caffeine adsorption on the surface of corannulene: A sensor study
Ullah, Z., Kim, H., Mary, Y. S., & Kwon, H. W. (2022) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2022.120592 · Cited by 55
Fullerene antioxidants decrease organophosphate-induced acetylcholinesterase inhibition in vitro
Ehrich, M. F., Tassell, R. L. V., Li, Y., Zhou, Z., & Kepley, C. L. (2010) · Toxicology in Vitro · doi:10.1016/j.tiv.2010.09.010 · Cited by 54
Jovanović, B., Anastasova, L., Rowe, E., & Palić, D. (2010) · Aquatic Toxicology · doi:10.1016/j.aquatox.2010.11.002 · Cited by 54
Fullerene C 60 and ascorbic acid protect cultured chromaffin cells against levodopa toxicity
Corona-Morales, A. A., Castell, A., Escobar, A., Drucker-Colı́n, R., & Zhang, L. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10456 · Cited by 54
Carboxylated fullerenes: Physico-chemical properties and potential applications
Semenov, K. N., Andrusenko, E. V., Charykov, N. A., Litasova, E. V., Panova, G. G., Penkova, A. V., Murin, I. V., & Piotrovskiy, L. B. (2017) · Progress in Solid State Chemistry · doi:10.1016/j.progsolidstchem.2017.09.001 · Cited by 55
Ngan, C. L., Basri, M., Tripathy, M., Karjiban, R. A., & Abdulmalek, E. (2014) · The Scientific World JOURNAL · doi:10.1155/2014/219035 · Cited by 53
Yang, J., Wang, K., Driver, J. W., Yang, J., & Barron, A. R. (2006) · Organic & Biomolecular Chemistry · doi:10.1039/b614298b · Cited by 53
Zhou, X., Xi, W., Luo, Y., Cao, S., & Wei, G. (2014) · The Journal of Physical Chemistry B · doi:10.1021/jp503458w · Cited by 50
Coccini, T., Caloni, F., Ramírez-Cando, L., & Simone, U. D. (2016) · Journal of Applied Toxicology · doi:10.1002/jat.3367 · Cited by 53
Ngan, C. L., Basri, M., Lye, F. F. A., Masoumi, H. R. F., Tripathy, M., Karjiban, R. A., & Abdulmalek, E. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s65689 · Cited by 49
Fullerene nanomaterials potentiate hair growth
Zhou, Z., Lenk, R., Dellinger, A. L., MacFarland, D. K., Kumar, K., Wilson, S. R., & Kepley, C. L. (2009) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2008.09.005 · Cited by 48
Vorobyov, V., Kaptsov, V., Gordon, R. Y., Makarova, E. G., Podolski, I. Y., & Sengpiel, F. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142469 · Cited by 47
Carbon-based Nanozymes: How Structure Affects Performance
He, J., Hou, Y., Zhang, Z., Zhang, J., Yan, X., Fan, K., & Liang, M. (2023) · Nano Biomedicine and Engineering · doi:10.26599/nbe.2024.9290053 · Cited by 46
Hybrid fullerene conjugates as vectors for DNA cell-delivery
Urîtu, C. M., Varganici, C., Ursu, E., Coroabǎ, A., Nicolescu, A. F., Dascălu, I., Peptanariu, D., Stan, D. L., Constantinescu, C. A., Simion, V., et al. (2015) · Journal of Materials Chemistry B · doi:10.1039/c4tb02040e · Cited by 46
Separation and purification of fullerenols for improved biocompatibility
Li, J., Zhang, M., Sun, B., Xing, G., Song, Y., Guo, H., Chang, Y., Ge, Y., & Zhao, Y. (2011) · Carbon · doi:10.1016/j.carbon.2011.08.073 · Cited by 46
Binding fullerenol C60(OH)24 to dsDNA
Ungurenasu, C., Pinteala, & Dascalu (2009) · International Journal of Nanomedicine · doi:10.2147/ijn.s6630 · Cited by 46
Revolutionary Impact of Nanodrug Delivery on Neuroscience
Khanbabaie, R., & Jahanshahi, M. (2012) · Current Neuropharmacology · doi:10.2174/157015912804499456 · Cited by 47
Hassanzadeh, P., Atyabi, F., & Dinarvand, R. (2017) · Life Sciences · doi:10.1016/j.lfs.2017.06.001 · Cited by 46
Gonchar, O. O., Maznychenko, A. V., Klyuchko, O. M., Im, M., Butowska, K., Borowik, A., Piosik, J., & Sokolowska, I. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115444 · Cited by 45
Troshin, P. A., Peregudov, A. S., Troyanov, S. I., & Lyubovskaya, R. N. (2008) · Russian Chemical Bulletin · doi:10.1007/s11172-008-0126-4 · Cited by 44
Akhtar, M. J., Kumar, S., Murthy, R. C., Ashquin, M., Khan, M. I., Patil, G., & Ahmad, I. (2010) · Toxicology in Vitro · doi:10.1016/j.tiv.2010.03.002 · Cited by 43
Proteins conjugated to poly(butyl cyanoacrylate) nanoparticles as potential neuroprotective agents
Reukov, V. V., Maximov, V. D., & Vertegel, A. A. (2010) · Biotechnology and Bioengineering · doi:10.1002/bit.22958 · Cited by 43
Revolutionary Impact of Nanodrug Delivery on Neuroscience
Khanbabaie, R., & Jahanshahi, M. (2012) · Current Neuropharmacology · doi:10.2174/157015912804143513 · Cited by 44
NEUROSURGERY IN THE REALM OF 10−9, PART 2
Elder, J. B., Liu, C. Y., & Apuzzo, M. L. J. (2008) · Neurosurgery · doi:10.1227/01.neu.0000315995.73269.c3 · Cited by 42
Yudoh, K. (2009) · International Journal of Nanomedicine · doi:10.2147/ijn.s7505 · Cited by 41
Physico-chemical properties of the C60-tris-malonic derivative water solutions
Semenov, K. N., Charykov, N. A., Murin, I. V., & Pukharenko, Y. V. (2014) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2014.11.019 · Cited by 40
Sumi, N., & Chitra, K. C. (2019) · Aquatic Toxicology · doi:10.1016/j.aquatox.2019.03.003 · Cited by 39
Kraevaya, O. A., Peregudov, А. S., Godovikov, I. A., Shchurik, E. V., Martynenko, V. M., Shestakov, A. F., Balzarini, J. M., Schols, D., & Troshin, P. A. (2019) · Chemical Communications · doi:10.1039/c9cc08400b · Cited by 39
Biologically active water-soluble fullerene adducts: Das Glasperlenspiel (by H. Hesse)?
Sharoyko, V. V., Ageev, S. V., Podolsky, N. E., Petrov, A. V., Litasova, E. V., Vlasov, T. D., Vasina, L. V., Murin, I. V., Piotrovskiy, L. B., & Semenov, K. N. (2020) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2020.114990 · Cited by 39
Gao, J., Wang, H. L., Shreve, A. P., & Iyer, R. S. (2010) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.12.025 · Cited by 40
de la Torre, M. D. L., Rodrigues, A. G. P., Tomé, A. C., Silva, A. M. S., & Cavaleiro, J. A. S. (2004) · Tetrahedron · doi:10.1016/j.tet.2004.03.003 · Cited by 36
Carbon Nanomaterial-Based Hydrogels as Scaffolds in Tissue Engineering: A Comprehensive Review
Stocco, T. D., Zhang, T., Dimitrov, E., Ghosh, A., da Silva, A. M. H., Melo, W., Tsumura, W., Silva, A. D. R., de Sousa, G. F., Viana, B. C., et al. (2023) · International Journal of Nanomedicine · doi:10.2147/ijn.s436867 · Cited by 35
Kosar, N., Tahir, H., Ayub, K., Gilani, M. A., & Mahmood, T. (2021) · Journal of Physics and Chemistry of Solids · doi:10.1016/j.jpcs.2021.109972 · Cited by 35
Cytoprotective activities of water-soluble fullerenes in zebrafish models
Beuerle, F., Witte, P., Hartnagel, U., Lebovitz, R. M., Parng, C., & Hirsch, A. (2007) · Journal of Experimental Nanoscience · doi:10.1080/17458080701502091 · Cited by 35
Evaluation of the fullerene compound DF-1 as a radiation protector
Brown, A. P., Chung, E. J., Urick, M. E., Shield, W. P., Sowers, A. L., Thetford, A., Shankavaram, U. T., Mitchell, J. B., & Citrin, D. E. (2010) · Radiation Oncology · doi:10.1186/1748-717x-5-34 · Cited by 34
Bozdaganyan, M. E., Orekhov, P. S., Shaytan, A. К., & Шайтан, К. В. (2014) · PLoS ONE · doi:10.1371/journal.pone.0102487 · Cited by 34
Sumanene as a delivery carrier for methimazole drug: DFT, AIM, SERS and solvent effects
Al-Otaibi, J. S., Mary, Y. S., Mary, Y. S., Mondal, A., Acharjee, N., & Churchill, D. G. (2022) · Computational and Theoretical Chemistry · doi:10.1016/j.comptc.2022.113811 · Cited by 34
Synthesis and antioxidant activity of [60]fullerene–flavonoid conjugates
Enes, R. F., Farinha, A. S. F., Tomé, A. C., Cavaleiro, J. A. S., Amorati, R., Petrucci, S., & Pedulli, G. F. (2008) · Tetrahedron · doi:10.1016/j.tet.2008.10.066 · Cited by 34
New non-oral drug delivery systems for Parkinson's disease treatment
Md, S., Haque, S., Sahni, J. K., Baboota, S., & Ali, J. (2011) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2011.556616 · Cited by 33
Beuerle, F., & Hirsch, A. (2009) · Chemistry - A European Journal · doi:10.1002/chem.200900329 · Cited by 32
Devane, R. H., Jusufi, A., Shinoda, W., Chiu, C., Nielsen, S. O., Moore, P. B., & Klein, M. L. (2010) · The Journal of Physical Chemistry B · doi:10.1021/jp1070264 · Cited by 32
Vávrová, J., Řezáčová, M., & Pejchal, J. (2012) · Journal of Applied Biomedicine · doi:10.2478/v10136-012-0002-2 · Cited by 32
Antioxidant action of sugar-pendant C60 fullerenes
Horie, M., Fukuhara, A., Saito, Y., Yoshida, Y., Hiroe, S., Ohi, H., Obata, M., Mikata, Y., Yano, S., & Niki, E. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.08.067 · Cited by 31
NF-κB inhibitors that prevent foam cell formation and atherosclerotic plaque accumulation
Plotkin, J. D., Elias, M. G., Dellinger, A. L., & Kepley, C. L. (2017) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2017.04.013 · Cited by 31
Carbon Nanotubes as Plant Growth Regulators
Patel, A., Tiwari, S., Parihar, P., Singh, R., & Prasad, S. M. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811488-9.00002-0 · Cited by 32
Cayuela, A., Soriano, M. L., & Valcárcel, M. (2016) · The Analyst · doi:10.1039/c5an01910a · Cited by 30
Carboxyfullerene nanoparticles alleviate acute hepatic injury in severe hemorrhagic shock
Chen, G., Song, X., Wang, B., You, G., Zhao, J., Xia, S., Zhang, Y., Zhao, L., & Zhou, H. M. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.10.022 · Cited by 29
Nanotechnology: A Promising Targeted Drug Delivery System for Brain Tumours and Alzheimer's Disease
Unnisa, A., Greig, N. H., & Kamal, M. A. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220328125206 · Cited by 28
Raghavan, A., Radhakrishnan, M., Soren, K., Wadnerkar, P., Kumar, A., Chakravarty, S., & Ghosh, S. (2023) · ACS Applied Bio Materials · doi:10.1021/acsabm.3c00099 · Cited by 29
Antioxidant Properties of Water-Soluble Fullerene Derivatives
Beuerle, F., Lebovitz, R. M., & Hirsch, A. (2008) · Carbon materials: chemistry and physics/Carbon materials · doi:10.1007/978-1-4020-6845-4_3 · Cited by 29
Growth and Potential Damage of Human Bone-Derived Cells on Fresh and Aged Fullerene C60 Films
Kopová, I., Bačáková, L., Lavrentiev, V., & Vacik, J. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14059182 · Cited by 29
Chaturvedi, R. K., Agrawal, A. K., Seth, K., Shukla, S., Chauhan, S., Shukla, Y., Sinha, C., & Seth, P. K. (2003) · International Journal of Developmental Neuroscience · doi:10.1016/s0736-5748(03)00087-x · Cited by 29
Introduction to Nanotechnology
Gordon, A. T., Lutz, G. E., Boninger, M. L., & Cooper, R. A. (2007) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/phm.0b013e318031ee1a · Cited by 28
Biocompatibility of a nanocomposite based on Aerosil 380 and carboxylated fullerene C60[C(COOH)2]3
Sharoyko, V. V., Iurev, G. O., Николаевич, П. В., Meshcheriakov, A. A., Ageev, S. V., Ivanova, D. A., Petrov, A. V., Luttsev, M. D., Нащекин, А. В., Iamalova, N. R., et al. (2021) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2021.03.007 · Cited by 28
Regenerative nanomedicine and the treatment of degenerative retinal diseases
Zarbin, M. A., Montemagno, C. D., Leary, J. F., & Ritch, R. H. (2011) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.167 · Cited by 28
Gul, M. Z., Kalam, S., Singh, R., & Ankati, S. (2015) · Pharmacologia · doi:10.5567/pharmacologia.2015.11.20 · Cited by 28
Modulation of Tumor Necrosis Factor-mediated Cell Death by Fullerenes
Harhaji-Trajkovic, L. M., Isaković, A., Vucicevic, L. M., Janjetović, K., Misirkic-Marjanovic, M., Marković, Z. M., Marković, B. M. T., Nikolić, N., Vranješ‐Đurić, S., Nikolić, Z., et al. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9486-y · Cited by 27
Vapa, I., Torres, V. M., Djordjevic, A. N., Vasović, V., Čonić, B. S., Dragojevic-Simic, V. M., & Popović, J. K. (2012) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/s13318-012-0092-y · Cited by 27
New Technology and Clinical Applications of Nanomedicine
Zuo, L., Wei, W., Morris, M. A., Wei, J., Gorbounov, M., & Wei, C. (2007) · Medical Clinics of North America · doi:10.1016/j.mcna.2007.05.004 · Cited by 27
Implantable microdevice for peripheral nerve regeneration: materials and fabrications
Bennet, D., & Kim, S. (2011) · Journal of Materials Science · doi:10.1007/s10853-011-5510-z · Cited by 27
Impact of physicochemical properties of engineered fullerenes on key biological responses
Rebecca, M., Hsing-Lin, W., Jun, G., Iyer, S., Gabriel, M. A., Jennifer, M., Shreve, A. P., Yuping, B., Chun-Chih, W., Zhong, C., et al. (2008) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2008.08.021 · Cited by 27
Bioactivity Study of the C60-L-Threonine Derivative for Potential Application in Agriculture
Panova, G. G., Serebryakov, E. B., Semenov, K. N., Charykov, N. A., Сергеевна, Ш. О., Andrusenko, E. V., Канаш, Е. В., Khomyakov, Y. V., Шпанев, А. М., Dulneva, L. L., et al. (2019) · Journal of Nanomaterials · doi:10.1155/2019/2306518 · Cited by 25
Synthesis and Water Solubility of Adamantyl-OEG-fullerene Hybrids
Bar‐Shir, A., Engel, Y., & Gozin, M. (2005) · The Journal of Organic Chemistry · doi:10.1021/jo0479359 · Cited by 25
Shukla, S., Agrawal, A. K., Chaturvedi, R. K., Seth, K., Srivastava, N., Sinha, C., Shukla, Y., Khanna, V. K., & Seth, P. K. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02715.x · Cited by 23
Dwarakanath, P. R., Abinaya, K., Nagasathiya, K., Sakthivelu, M., Gopinath, S. C. B., & Pachaiappan, R. (2022) · Biomass Conversion and Biorefinery · doi:10.1007/s13399-022-03572-0 · Cited by 23
Dendrimer–Fullerenol Soft-Condensed Nanoassembly
Bhattacharya, P., Kim, S. H., Chen, P., Chen, R., Spuches, A. M., Brown, J. M., Lamm, M. H., & Ke, P. C. (2012) · The Journal of Physical Chemistry C · doi:10.1021/jp3036692 · Cited by 23
Effect of Self-Assembly of Fullerene Nano-Particles on Lipid Membrane
Zhang, S., Mu, Y., Zhang, J. Z. H., & Xu, W. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077436 · Cited by 23
Kotelnikova, R. A., Smolina, A. V., Grigoryev, V. V., Faingold, I. I., Mishchenko, D. V., Rybkin, A. Y., Poletaeva, D. A., Van’kin, G. I., Zamoyskiy, V. L., Voronov, I., et al. (2014) · MedChemComm · doi:10.1039/c4md00194j · Cited by 23
Neuroprotection in Parkinson’s disease: love story or mission impossible?
Linazasoro, G. (2002) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2.3.403 · Cited by 22
Nanopharmaceuticals: Innovative theranostics for the neurological disorders
Hassanzadeh, P. (2014) · Biomedical Reviews · doi:10.14748/bmr.v25.1043 · Cited by 21
Agrawal, A. K., Chaturvedi, R. K., Shukla, S., Seth, K., Chauhan, S., Ahmad, A., & Seth, P. K. (2004) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2004.08.001 · Cited by 21
Chen, L., Miao, Y., Chen, L., Xu, J., Wang, X., Zhao, H., Shen, Y., Hu, Y. B., Bian, Y., Shen, Y., et al. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.07.030 · Cited by 20
Histopathology of fathead minnow (Pimephales promelas) exposed to hydroxylated fullerenes
Jovanović, B., Whitley, E. M., & Palić, D. (2013) · Nanotoxicology · doi:10.3109/17435390.2013.828794 · Cited by 20
Non-conventional compounds with potential therapeutic effects against Alzheimer’s disease
de Castro, A. A., Soares, F. V., Pereira, A. F., Polisel, D. A., Caetano, M. S., Leal, D. H. S., da Cunha, E. F. F., Nepovimová, E., Kuča, K., & Ramalho, T. C. (2019) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2019.1608823 · Cited by 20
Gudkov, S. V., Simakin, A. V., Sarimov, R. M., Kurilov, A. D., & Chausov, D. N. (2021) · Nanomaterials · doi:10.3390/nano11112804 · Cited by 19
Inui, S., Aoshima, H., Ito, M., Kobuko, K., & Itami, S. (2012) · PubMed · Cited by 19
Kostyuk, S. V., Proskurnina, E. V., Savinova, E. A., Ershova, E. S., Kraevaya, O. A., Kameneva, L. V., Umriukhin, P. E., Dolgikh, O. А., Kutsev, S. I., Troshin, P. A., et al. (2020) · Nanomaterials · doi:10.3390/nano10071405 · Cited by 19
(2021) · Biointerface Research in Applied Chemistry · doi:10.33263/briac121.940960 · Cited by 21
Takada, H., Mimura, H., Xiao, L., Islam, R., Matsubayashi, K., Ito, S., & Miwa, N. (2006) · Fullerenes Nanotubes and Carbon Nanostructures · doi:10.1080/15363830600665433 · Cited by 19
Chaturvedi, R. K., Shukla, S., Seth, K., & Agrawal, A. K. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2007.12.016 · Cited by 19
Nanomedicine against Alzheimer’s and Parkinson’s Disease
Tandon, A., Singh, S. J., & Chaturvedi, R. K. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666201021140904 · Cited by 20
Catalytic mechanism and application of nanozymes
Li, Z., Feng, K., Zhang, W., Ma, M., Gu, N., & Zhang, Y. (2018) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/n972018-00426 · Cited by 18
Evaluation of the Biodistribution of Serinolamide-Derivatized C60 Fullerene
Zaibaq, N. G., Pollard, A. C., Collins, M. J., Pisaneschi, F., Pagel, M. D., & Wilson, L. J. (2020) · Nanomaterials · doi:10.3390/nano10010143 · Cited by 18
Nedzvetsky, V. S., & Andrievsky, G. V. (2012) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000215 · Cited by 18
Synthesis of [60]fullerene–quercetin dyads
de la Torre, M. D. L., Tomé, A. C., Silva, A. M. S., & Cavaleiro, J. A. S. (2002) · Tetrahedron Letters · doi:10.1016/s0040-4039(02)00867-5 · Cited by 18
Panghal, A., & Flora, S. J. S. (2024) · Discover Nano · doi:10.1186/s11671-024-04135-0 · Cited by 20
Photo-labeling of C60 with 3-trifluoromethyl-3-phenyldiazirine
Sato, S., Yamada, M., Wakahara, T., Tsuchiya, T., Ishitsuka, M. O., Akasaka, T., & Liu, M. T. H. (2007) · Tetrahedron Letters · doi:10.1016/j.tetlet.2007.07.027 · Cited by 17
Podolski, I. Y., Kondratjeva, E. V., Gurin, S. S., Анатольевна, Д. М., & Piotrovsky, L. B. (2004) · Fullerenes Nanotubes and Carbon Nanostructures · doi:10.1081/fst-120027201 · Cited by 16
Nezhadi, A., Ghazi, F., Rassoli, H., Bakhtiari, M., Ataei, Z., Asl, S. S., & Mehdizadeh, M. (2011) · Pathophysiology · doi:10.1016/j.pathophys.2011.05.004 · Cited by 16
Liu, J., & Huang, H. (2007) · Neuroscience Bulletin · doi:10.1007/s12264-007-0056-4 · Cited by 16
High Catalytic Activity of Dendritic C60 Monoadducts in Metal‐Free Superoxide Dismutation
Liu, G., Filipović, M. R., Ivanović‐Burmazović, I., Beuerle, F., Witte, P., & Hirsch, A. (2008) · Angewandte Chemie · doi:10.1002/ange.200800008 · Cited by 16
Cytoprotective properties of a fullerene derivative against copper
Ratnikova, T. A., Bebber, M. J., Huang, G. Q., Larcom, L. L., & Ke, P. C. (2011) · Nanotechnology · doi:10.1088/0957-4484/22/40/405101 · Cited by 15
Metadata
- Authors
- Dugan, L. L., Lovett, E. G., Quick, K. L., Lotharius, J., Lin, T. T., & O'Malley, K. L.
- Affiliations
- Washington University in St. Louis (US)
- Corresponding author
- Dugan, L.L.
- ORCID
- Dugan, L.L.
- Venue
- Parkinsonism & Related Disorders
- Publisher
- Elsevier BV
- Published
- 2001-07
- Volume
- 7
- Issue
- 3
- Pages
- 243-246
- ISSN
- 1353-8020 (ISSN-L)
- OpenAlex
- W2126036130
- Cited by
- 338
- References
- 9
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 16 · 2023: 20 · 2022: 14 · 2021: 14 · 2020: 20 · 2019: 14 · 2018: 13 · 2017: 9 · 2016: 10 · 2015: 14 · 2014: 15 · 2013: 12 · 2012: 22
- FWCI
- 4.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Parkinsonism & Related Disorders (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Chemistry › Organic Chemistry › Fullerene Chemistry and Applications
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review